At a glance
- Originator Nonindustrial source
- Class Antivirals; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 19 May 2000 New profile
- 19 May 2000 Preclinical development for Viral infections in Italy (Unknown route)